Apyx Medical Corporation Common Stock (APYX) is a publicly traded Healthcare sector company. As of July 23, 2026, APYX trades at $3.92 with a market cap of $173.49M and a P/E ratio of -14.64. APYX moved +0.00% today. Year to date, APYX is +11.71%; over the trailing twelve months it is +73.78%. Its 52-week range spans $0.76 to $5.08. Analyst consensus is buy with an average price target of $6.50. Rallies surfaces APYX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for APYX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $3.92 |
| Market Cap | $173.49M |
| P/E Ratio | -14.64 |
| EPS | $-0.27 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.08 |
| 52-Week Low | $0.76 |
| Volume | 4.23K |
| Avg Volume | 0 |
| Revenue (TTM) | $52.84M |
| Net Income | $-11.11M |
| Gross Margin | 62.53% |
2 analysts cover APYX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.50.